Historically, high-grade serous ovarian cancers (HGSOCs) were thought to arise from ovarian surface epithelial cells (OSECs) but recent data implicate fallopian tube secretory epithelial cells (FTSECs) as the major precursor. We performed transcriptomic and epigenomic profiling to characterize molecular similarities between OSECs, FTSECs and HGSOCs. Transcriptomic signatures of FTSECs were preserved in most HGSOCs reinforcing FTSECs as the predominant cell-of-origin; though an OSEC-like signature was associated with increased chemosensitivity (Padj = 0.03) and was enriched in proliferative-type tumors, suggesting a dualistic model for HGSOC origins. More super-enhancers (SEs) were shared between FTSECs and HGSOCs than between OSECS and HGSOCs (P < 2.2 x 10 -16
Invasive epithelial ovarian cancers are a heterogenous group of tumors comprising several major histological subtypes: high-grade serous, low-grade serous, endometrioid, clear cell and mucinous. Highgrade serous ovarian cancer (HGSOC) is the most common subtype, comprising around two-thirds of all invasive cases. Our understanding of the cellular origins of HGSOC and key transcription factor networks deregulated during HGSOC development has been restricted by the lack of substantial molecular profiling data for the suggested precursor tissues, ovarian surface epithelial cells (OSECs) and fallopian tube secretory epithelial cells (FTSECs). Historically, HGSOCs were thought to arise from OSECs, an atypical epithelial cell type with mesothelial features and inherent phenotypic plasticity and heterogeneity 1, 2 .
However, examples of early-stage ovarian carcinoma arising from OSECs in vivo are scare, and the discovery of occult carcinomas in the fallopian tubes of BRCA1/2 mutation carriers provided evidence to support an alternative hypothesis that the fallopian epithelium harbors the cell-of-origin for HGSOC [3] [4] [5] [6] [7] .
Subsequent studies support a tubal origin for HGSOCs not associated with highly penetrant gene mutations, suggesting that HGSOCs arise from FTSECs in at least 50% of cases [8] [9] [10] . However, in a proportion of cases there remains no evidence of fallopian involvement, which raises the possibility that HGSOCs could originate from more than one tissue type. The large-scale molecular data sets required to fully evaluate the relationships of OSEC and FTSECs to HGSOC have been lacking, and so in the current study we established transcriptome-wide signatures in 188 normal cells representing these two putative origins of HGSOC. We used machine learning to quantify the similarities between OSECs and FTSECs to HGSOCs transcriptomes as a molecular approach to characterizing disease origins. In addition, we integrated transcriptomic data with epigenetic maps for these cell types, to characterize tissue-specific super-enhancer landscapes, and to identify putative transcription factors driving transcriptional deregulation during serous ovarian tumorigenesis.
Results

Expression profiling of putative ovarian cancer precursor cells
One approach to exploring cellular origins of cancer is to quantify similarities and differences between molecular signatures of tumors and the proposed tissues of origin 11 ; based on the hypothesis that the molecular blueprint of the normal precursor cell is maintained in the developed tumor. We applied this approach to explore HGSOC origin by performing RNA-sequencing (RNA-seq) on an extensive series of normal cells isolated from the two major proposed precursor tissue types, ovarian surface epithelial cells (OSECs; n = 114) and fallopian tube secretory epithelial cells (FTSECs; n = 74). Cell samples were derived from 132 individuals, with both OSECs and FTSECs isolated from the same patient in 56 cases 12, 13 (Supplementary Table 1 ). For one sample, we replicated the RNA sequencing for quality control purposes; expression profiles from this samples were highly correlated (Pearson's correlation r = 0.98) ( Supplementary Fig. 1 ). We found no associations with experimental or epidemiological variables (where available), including sample preparation patient age or ethnicity (data not shown).
Using transcriptome-wide principal component analysis (PCA) to compare expression signatures between OSECs and FTSECs, the two cell types largely stratified according to their molecular profiles (Fig.   1a,b) . We identified the 87 genes that were the most differentially expressed between OSECs and FTSECs , Fig. 1d, Supplementary Table 2 ). These included MUC16 (which encodes ovarian cancer screening marker CA125) and CDH1 (E-Cadherin), genes known to be differentially expressed between these cell types (Fig. 1c, Supplementary Fig. 2 ). Novel, highly ).
Transcriptomic Relationships between OSECs, FTSECs and HGSOCs
We applied machine learning algorithms to evaluate the molecular relationships between transcriptomic profiles of OSECs and FTSECs and 394 primary HGSOCs profiled by The Cancer Genome Atlas (TCGA). To correct for differences in read depth and RNA-seq methods between this study and TCGA, we aligned, batch corrected and normalized all three data sets (OSEC, FTSEC and TCGA) together (see Methods). We first defined cell-type specific signatures of OSECs and FTSECs and then applied a One-class logistic regression (OCLR) methodology 14 . Area under the curve (AUC) statistics generated using a leave-one-out approach indicated that the OCLR models performed with high specificity (average AUC for OSECs = 0.99 and for FTSECs = 0.97). OCLR models provide a score for each sample and for each category, which is rescaled between zero and one, where zero implies no similarity and one implies high similarity. We applied the OCLR models to HGSOCs to evaluate which cell type -OSECs or FTSECswas most highly correlated with HGSOC, thereby indicating which cell type is the most likely cell-of-origin.
HGSOC samples were randomized and divided into two equally sized groups (n = 197), designated the training set and the validation set. Each set included similar numbers of the four HGSOC molecular subgroups -differentiated, immunoreactive, mesenchymal and proliferative, classified based on gene expression signatures. In both the training and validation data sets, we observed a greater proportion of HGSOCs with higher FTSEC scores compared to OSEC scores. In the training set 103/197 tumors (52%) had an FTSEC score > 0.5, while only 20/197 tumors (10%) had an OSEC score > 0.5. In the validation set 124/197 tumors (63%) and 82/197 tumors (42%) had FTSEC and OSEC scores > 0.5, respectively (Fig.   2a,b) . Taken together, these data indicate that the molecular signatures of HGSOCs are more similar to FTSECs than OSECs. There was a weak negative correlation between tumor FTSEC and OSEC scores ( Supplementary Fig. 3 ) (Pearson's product-moment correlation = -0.16, P = 0.002). Consistent with our machine learning observations, in a PCA performed using all expressed genes, FTSECs cluster more closely to HGSOCs than OSECs ( Supplementary Fig. 4 ).
We also evaluated if FTSEC and OSEC scores correlated with clinical and molecular features of HGSOCs 15, 16 . In both the training and validation data sets, mesenchymal-type HGSOCs had significantly higher FTSEC OCLR scores (Padj < 0.02 in the training and validation cohort, Fig. 2c Supplementary Figs. 5,6 ). We found no significant associations for FTSECs, but tumors with high OSEC scores were associated with older age at diagnosis (Padj = 0.005, normalized enrichment score = 1.6). Higher OSEC score was also associated with increased sensitivity to chemotherapy (Padj = 0.03, normalized enrichment score = 1.5) (Supplementary Fig. 6 ).
Identifying Epigenomic and Transcriptomic Interactions
We used chromatin immunoprecipitation sequencing (ChIP-seq) to characterize epigenomic landscapes in OSECs, FTSECs and HGSOCs, focusing on super-enhancers (SEs), which are dense clusters of highly active chromatin that typically localize with master regulators of cellular identity. We generated , Fig. 3a,b) . Using the transcriptomic data described above, we verified tissue-specific overexpression of genes located at tissuerelevant SE loci (Fig. 3c,f,i) , and identified novel candidate target genes regulated by SEs in each cell type .
These included SULT1B1 in OSECs (Fig. 3d,e) ; the Tripartite Motif Containing 55 (TRIM55) gene in FTSECs (Fig. 3g,h ) and the SOX18 transcription factor in HGSOCs (Fig. 3j,k) . Of particular note, the PAX8 transcription factor was overexpressed in both FTSECs and HGSOCs and coincides with a SE detected in both cell types at this locus; PAX8 is a well-established biomarker that is ubiquitously expressed in FTSECs and is overexpressed in the majority of primary HGSOCs [21] [22] [23] ( Supplementary Fig. 7 ).
Finally, we performed a targeted analysis of genes associated with DNA binding, transcription factor activity and chromatin remodeling to identify putative novel drivers of transcriptional deregulation during HGSOC development from FTSECs and/or OSECs. For nine of the most overexpressed transcriptional regulators in HGSOCs (Fig. 4a) , high-quality ChIP-seq data were available from cistrome.org. Using these
ChIP-seq data sets we quantified how many of the most differentially expressed genes in HGSOCs were located near to (within 50 kbp) a factor-specific peak compared to matched random peaks (see Methods).
Factor-specific peaks for regulators including SPI1, CTCFL, NFE2, ASCL2 and GRHL2 were more numerous in the vicinity of HGSOC DEGs (P < 10 -30 for a comparison to FTSECs and P < 10 -50 for a comparison to OSECs) than randomly generated matched sets of background peaks (100 iterations, P < 0.01 Fig 
Discussion
There remains debate about the cellular origins of high-grade serous ovarian cancer. Over the last few years the fallopian tube, and specifically the secretory epithelial cell component (FTSECs), has emerged as a likely origin. This is based on the identification of early stage precursor lesions in the fallopian tube that express secretory cell lineage markers and harbor TP53 mutations, particularly in fallopian tube fimbriae 3, 4, 8, 10, 24 . In addition, in vitro and in vivo models studies 12 While our study shows clear differences between the transcriptomic profiles of OSECs and FTSECs, there are some caveats to the study design that could influence interpretation of our findings. One of these is the potential impact of short term culture on the gene expression profiles of primary OSECs and FTSECs.
Neither cell type is readily amenable to microdissection from primary tissues -OSECs are a scarce population on the surface of the ovary and FTSECs are intercalated with ciliated cells not currently thought to be precursors of serous carcinogenesis; thus culturing cells was our preferred approach to obtaining sufficient purified OSEC/FTSEC cell material on which to perform in-depth molecular profiling studies without having to pool samples across patients. To limit artifacts induced by cell culture, cells were not genetically modified and the procedures for primary culture were optimized for each cell type specifically.
Moreover, our results are closely reflected by results of a recent molecular profiling study which compared an independent cohort of HGSOCs to signatures derived from a small cohort of fallopian (n=3 pooled samples) or ovarian brushing (n=4 pooled samples) and observed similar trends: that the majority of ; suggesting that short-term culture did not substantially influence our analyses.
Little is known about the key transcription factors (TFs) driving oncogenesis in HGSOC. PAX8 is a TF known to be highly expressed in FTSECs and functionally involved in disease development 22, 30, [33] [34] [35] . We found that PAX8 is marked by a super-enhancer in both FTSECs and HGSOCs. We also identified ELF3
and EHF as putative drivers of the transformation of FTSECs and OSECs respectively, both of which have been implicated in ovarian cancer development 36, 37 . Of the four genes highly expressed in OSECs, two were transcriptional regulators: GATA4 is a developmental zinc finger TF and NR5A1 is a transcriptional activator involved in sex determination and differentiation of steroidogenic tissues. Both GATA4 and NR5A1
were highly expressed in proliferative type HGSOCs, suggesting these TF networks may specifically be involved in the development of this tumor subgroup.
Compared to previous studies, these investigations represent a significant advance in both scale and scope of the molecular profiling performed OSECs and FTSECs were harvested from women diagnosed with ovarian, uterine or cervical cancer, and were histologically normal. Short-term cultures were established as previously described 12, 13 . Briefly,
OSECs were harvested using a cytobrush and cultured in NOSE-CM media containing 15% fetal bovine serum (FBS, Hyclone), 34 μg ml -1 bovine pituitary extract, 10 ng ml -1 epidermal growth factor (Life Technologies), 5 μg ml -1 insulin and 500 ng ml -1 hydrocortisone (Sigma-Aldrich). FTSECs were harvested by Pronase/DNase I digestion (Roche and Sigma-Aldrich, respectively) for 48-72 hours at 4°C and cultured on collagen I (Sigma-Aldrich) using DMEM/F12 base media supplemented with 2% Ultroser G (Pall Corporation). At ~80% confluency, cells were lysed using the QIAzol reagent and RNA extracted using the RNeasy Mini kit (both QIAgen). RNA sequencing was performed by the University of Southern California
Epigenome Core Facility.
RNAseq data processing and QC
All data analysis was performed using 'R' and 'Bioconductor', and packages therein. RNAseq data for 394
HGSOC samples was obtained from The Cancer Genome Atlas (TCGA) data portal as protected data (raw sequencing, fastq files) and downloaded via CGHub's geneTorrent. Data was aligned to a reference genome (hg19) using STAR. And quality control of aligned samples performed using RSeQC. GC bias and batch effect corrections were performed using EDASeq and 'sva'. To adjust for batch effects we used an empirical Bayes framework (comBat), available in 'sva'.
Differential gene expression analyses
After normalization, the data matrix contained 21,071 genes. Parametric statistics (Student's T-test) and supervised hierarchical clustering were performed to identify genes differentially expressed in pairwise comparisons of two groups of interest (OSEC, FTSEC and HGSOC). P-values were adjusted using Benjamini-Hochberg step-up procedure.
Machine learning analyses
We applied a machine learning approach to define a probabilistic score associated to both normal cell types, and infer tumor origins. A One-class classifier was selected as this method can handle non-traditional supervised scenarios where no negative class can be defined. The classifiers were implemented by the gelnet R-package version 1.2.1. Data were mean centered considering all samples together, then each cell type used separately to train and test the models. To train the OSEC model we considered all OSEC samples, with a coefficient for the L1-norm penalty equal to 0 and coefficient for the L2-norm penalty equal to 1 as arguments of gelnet function. We then evaluated the model performance through leave-one-out procedure where the left-out OSEC sample was mixed into FTSEC sample background. The accuracy was evaluated via the Area Under the ROC curve method, with 99% of OSEC samples correctly predicted, on average, and 97% of FTSECs correctly predicted. We then tested the model prediction behaviour when applied to HGSOCs from TCGA. We took advantage of the fast gene set enrichment analysis (fgsea, version 1.2.1, http://bioconductor.org/packages/fgsea/) method to evaluate enrichment of clinical attributes across the tumor OCLR scores from both FTSEC and OSEC models. We applied the fgsea function with the parameter nperm equal to 10,000.
Tissue ChIP-seq in HGSOC specimens
Tissue ChIP-seq was performed based on the methods described in Pomerantz et al 2015.
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. One 3 mm core was isolated from an epithelial-rich portion of tumor, and pulverized using the Covaris CryoPrep system (Covaris, Woburn, MA), set to an intensity of 4. Tissues were fixed using 1% formaldehyde (Thermo 
ChIP-seq data analysis
The AQUAS pipeline (https://github.com/kundajelab/chipseq_pipeline) was used to processed ChIP-seq data. Reads were aligned to the reference human genome (hg19), filtered by read quality and duplicate reads removed. macs2 (https://pypi.python.org/pypi/MACS2) was used for peak calling. For the cell lines, two technical replicates were generated and the final peaks were obtained using a naive overlap approach, where the peaks are included if they overlap more than 50% between the two technical replicates. Figure   10 ). After alignment, homer (http://homer.ucsd.edu/homer/) was used to identify super-enhancers, using a super slope parameter of 2 and a minimum distance of ten thousand. For defining a set of HGSOC SEs, we selected SEs that were called in at least two HGSOC samples. For the FTSEC set of SEs, SEs were called individually in each technical replicate, then, all the SEs that overlapped both technical replicates within the same cell line (FTSEC33 or FTSEC246) were selected to get the union set. We used a similar approach to get the union set of SEs for the OSEC cell lines.
Cistrome TF analyses
From the Cistrome database (cistrome.org), we selected and downloaded BED peak files for experiments passing 3/6 quality control filters. Data sets used are listed in the Online Methods. The following data sets were included: HOXC9: GSM848788, GSM848789; LXH2: GSM1208644,GSM1567049; GLIS1:
ENCSR482BBZ, GSM1208752, GSM2026832, GSM803384; GATA4: ENCSR590CNM, GSM1505646, GSM1505647, GSM1505651, GSM1505657; HNF1B: GSM1239408, GSM1505680, GSM1505681, GSM1505682, GSM1505683; EHF: GSM1208609, GSM1548071, GSM1548072; OVOL2: GSM1239518; ELF3: GSM1208732; SPI1: GSM1010843, GSM1370280, GSM1370292, GSM1421017, GSM1642769, GSM1703900; CTCFL: GSM1239559, GSM1817655, GSM1817659, GSM1817663, GSM1817668, GSM1817669, GSM803401; PITX1: GSM1208667; NFE2: GSM1067276, GSM1427076, GSM935414, GSM935652; ASCL2: GSM1208591; GRHL2: GSM1125982, GSM1125983, GSM1125984, GSM1239569.
We converted hg18 genomic positions to hg19 coordinates using the liftOver tool from UCSC (http://genome.ucsc.edu/cgi-bin/hgLiftOver). Where multiple data sets existed for a given factor, data set were merged to create a union peak set. Random peaks were generated maintaining the same chromosome proportion in the original peak file to create 100 iterations in each random peak simulation. To identify the number of genes associated to cistrome peaks we considered a distance window of 50 kbp from each TF peak coordinates using the distance() function from GenomicRanges package version 1.28.4. The P-value was calculated using the following expression: P = (r +1)/(n + 1), where r is the number of random values greater or equal than observation value and n is the number of random iterations.
Data and code availability
All raw RNA sequencing data are also accessible at http://tcgabiolinks.fmrp.usp.br/OvarianRNAseq/. The code used to perform the analyses is available as an Rmarkdown at:
http://tcgabiolinks.fmrp.usp.br/OvarianRNAseq/.
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